经皮&ldquo;瓣上瓣&rdquo;支架植入治疗急性主动脉瓣关闭不全的应用解剖

刘洁; 徐佰达; 凌秋洋; 王霄; 安冬梅; 曹丽; 白元; 宗刚军

doi:10.13418/j.issn.1001-165x.2016.05.001

中国临床解剖学杂志 ›› 2016, Vol. 34 ›› Issue (5) : 481-485. DOI: 10.13418/j.issn.1001-165x.2016.05.001

应用解剖

经皮“瓣上瓣”支架植入治疗急性主动脉瓣关闭不全的应用解剖

刘洁¹，　徐佰达¹，　凌秋洋¹，　王霄¹，　安冬梅¹，　曹丽¹，　白元²，　宗刚军¹

作者信息 +

Applied anatomy of percutaneous "valve-above-valve" stent implantation to treat the acute aortic insufficiency

LIU Jie¹, XU Bai-da¹, LING Qiu-yang¹, WANG Xiao¹, AN Dong-mei¹, CAO Li¹, BAI Yuan², ZONG Gang-jun¹

Author information +

文章历史 +

摘要

目的　为经皮“瓣上瓣”支架植入治疗急性主动脉瓣膜关闭不全提供相关应用解剖。方法　解剖5例外形大小正常的成年人心脏和升主动脉的标本；回顾性分析178例升主动脉CTA病人影像资料，其中男性131例，女性47例，以及85例主动脉瓣上造影（DSA）病人资料，其中男性45例，女性40例，测量不同位置升主动脉的内径及长度。结果　根据升主动脉CTA测得D1、D2、L1、L2分别为（30.5±2.3）、（25.5±1.8）、（36.5±3.6）、（31.2±4.1）mm，经体表面积标准化后得出的SD1、SD2、SL1、SL2分别为（17.1±1.2）、（14.2±0.9）、（21.4±1.1）、（17.8±1.3）mm；根据升主动脉DSA测量得出的D1’、D2’、L1’、L2’分别为（28.7±2.8）、（24.4±2.1）、（34.3±2.9）、（29.4±3.6）mm，经体表面积标准化后得出SD1’、SD2’、SL1’、SL2’分别为（16.0±1.4）、（13.5±1.2）、（19.7±1.6）、（16.7±2.0）mm 。结论　经皮主动脉“瓣上瓣”支架具有成功的动物实验研究背景，可作为一种新技术用于临床，其瓣膜支架的大小和形状的设计应根据升主动脉段的内径和长度来选择。

Abstract

Objective　To provide the anatomical basis for percutaneous "valve-above-valve" stent implantation in the treatment of the acute aortic insufficiency.　Methods　The normal adult hearts and the ascending aorta in 5 specimens with the same shape and size were dissected, the aortic CTA data of 178 cases were retrospectively analyzed, among which 131 cases were male, 47 cases female; and the aortic angiography data of 85 cases were retrospectively analyzed, among which 45 cases were male, 40 cases were female. The inner diameter and length of the ascending aorta in different location were measured.　Results　The inner diameter at the opening of the brachiocephalic trunk measuredby aorta CTA was (30.5±2.3)mm, the inner diameter at the opening of the coronary artery was (25.5±1.8)mm, and the distance from the midpoint to the two openings was (36.5±36.5) mm and (31.2±4.1) mm, respectively. After standardization of the body surface area, the values were respectively （17.1±1.2）,（14.2±0.9）,（21.4±1.1）and（17.8±1.3）mm; the above mentioned values measured in the same way by DSA were （28.7±2.8）,（24.4±2.1）,（34.3±2.9） and （29.4±3.6）mm, respectively. After standardization of the body surface area, the values were （16.0±1.4）,（13.5±1.2）,（19.7±1.6） and（16.7±2.0）mm, respectively.　Conclusion　There has been a successful animal experiment research background in the percutaneous "valve-above-valve" stent, which can be used for clinical purposes as a new technology. The size and shape of the "valve-above-valve" stent should be designed by the inner diameter and the length of the ascending aorta.

导出引用

刘洁,徐佰达,凌秋洋,王霄,安冬梅,曹丽,白元,宗刚军. 经皮“瓣上瓣”支架植入治疗急性主动脉瓣关闭不全的应用解剖[J]. 中国临床解剖学杂志. 2016, 34(5): 481-485 https://doi.org/10.13418/j.issn.1001-165x.2016.05.001

LIU Jie, XU Bai-da, LING Qiu-yang, WANG Xiao, AN Dong-mei, CAO Li, BAI Yuan, ZONG Gang-jun. Applied anatomy of percutaneous "valve-above-valve" stent implantation to treat the acute aortic insufficiency[J]. Chinese Journal of Clinical Anatomy. 2016, 34(5): 481-485 https://doi.org/10.13418/j.issn.1001-165x.2016.05.001

参考文献

[1] Calhoon JH, Hoffmann TH, Trinkle JK, et al. Management of blunt rupture of the heart[J]. Trauma, 1986, 26(20):495-502.
[2] Frazee RC, Mucha P Jr, Famell MB, et al. Objective evaluation of blunt cardiac trauma[J]. Trauma, 1999, 26(6):510-520
[3] Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis[J]. Circulation， 2007, 116(7):755-763.
[4] Cribier A, Eltehaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description [J]. Circulation, 2002,106(24):3006-3008．
[5] Grube E, Schuler G, Feld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome[J]. Am Coll Cardiol, 2007,50(1):69-76.
[6] Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval[J]. EuroIntervention, 2008, 4(2):242-249.
[7] Zong GJ, Bai Y, Jiang HB, et al. Use of a novel valve stent for transcatheter pulmonary valve replacement: an animal study[J]. Thorac Cardiovasc Surg, 2009, 137(6):1363-1369.
[8] Rylski B, Desjardins B, Moser W, et al. Gender-related changes in aortic geometry throughout life [J]. Eur J Cardiothorac Surg, 2014, 45(5):805-811.
[9] 宗刚军，姜海滨，吴刚勇，等. 经皮“瓣上瓣”支架植入对急性主动脉瓣反流动物短期预后的影响[J]. 临床心血管病杂志，2016, 32(3):294-298.